Using phage as a platform to select cancer cell-targeting peptides

Xin Li1, Chuanbin Mao

  • 1Department of Chemistry & Biochemistry, Stephenson Life Sciences Center, University of Oklahoma, Norman, OK, USA.

Insights

Researchers identified specific peptides targeting SKBR-3 breast cancer cells using phage display. These peptides show potential for developing targeted cancer therapies and diagnostics.

Area of Science:

  • Oncology
  • Biotechnology
  • Molecular Biology

Background:

  • Developing targeted cancer therapies requires cancer-specific ligands.
  • Phage-displayed peptide libraries offer a method for selecting such ligands.
  • Identifying ligands for specific cancer cells like SKBR-3 breast cancer cells is crucial.

Purpose of the Study:

  • To describe methods for identifying SKBR-3 breast cancer cell-specific peptides.
  • To demonstrate the selection of both cell-surface-binding and cell-internalizing peptides.
  • To highlight the applicability of this method to other adherent cancer cells.

Main Methods:

  • Utilizing a phage-displayed random peptide library.
  • Employing selection strategies to identify peptides binding to SKBR-3 breast cancer cells.
  • Characterizing the selected peptides for cell-surface binding and internalization potential.

Main Results:

  • Successfully identified specific peptides targeting SKBR-3 breast cancer cells.
  • Demonstrated the capability to select peptides with cell-surface binding properties.
  • Showcased the selection of peptides capable of cell internalization.
  • Confirmed the method's adaptability for selecting targeting peptides for other adherent cancer cells.

Conclusions:

  • The described method effectively identifies cancer cell-specific peptides.
  • Selected peptides hold potential for early diagnostic systems against breast cancer.
  • Identified peptides can be incorporated into targeted therapeutic strategies for breast cancer.
  • This approach is versatile and applicable to various adherent cancer cell types.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
60.5K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K